Holen Sie sich die Stockscreener-App
1.58
9.72%
0.14
Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.95%
2.108
|
2.341 | 3.23 | 5.042 | 5.448 |
| Depreciation and Amortization |
16.00%
0.021
|
0.025 | 0.028 | 0.03 | 0.033 |
| Operating Income/Loss |
9.95%
-2.108
|
-2.341 | -3.23 | -5.042 | -5.448 |
| Nonoperating Income/Loss |
32.50%
0.053
|
0.04 | -0.036 | 0.103 | 0.105 |
| Income/Loss From Continuing Operations Before Tax |
10.69%
-2.055
|
-2.301 | -3.266 | -4.939 | -5.343 |
| Income/Loss From Continuing Operations After Tax |
10.69%
-2.055
|
-2.301 | -3.266 | -4.939 | -5.343 |
|
Net Income/Loss
|
10.69%
-2.055
|
-2.301 | -3.266 | -4.939 | -5.343 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
10.17
|
10.17 | - | 10.17 | 10.17 |
| Diluted Average Shares |
0.00%
10.17
|
10.17 | - | 10.17 | 10.17 |
| Basic Earnings Per Share |
13.04%
-0.20
|
-0.23 | -0.32 | -0.49 | -0.53 |
| Diluted Earnings Per Share |
13.04%
-0.20
|
-0.23 | -0.32 | -0.49 | -0.53 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):